Soluble RANKL expression in Lactococcus lactis and investigation of its potential as an oral vaccine adjuvant

BMC Immunology

Volumn 16, Issue 1, 2015, Pages

  Kim, Jeong In ^a   Park, Tae Eun ^a   Maharjan, Sushila ^a   Li, Hui Shan ^a   Lee, Ho Bin ^a   Kim, In Seon ^a   Piao, Dachuan ^a   Lee, Jun Yeong ^a   Cho, Chong Su ^a   Bok, Jin Duck ^a   Hong, Zhong Shan ^b   Kang, Sang Kee ^a   Choi, Yun Jaie ^a,b  

^a Seoul National University   (South Korea)

^b TIANJIN AGRICULTURAL UNIVERSITY   (China)

Author keywords

L. lactis; M cells; Mucosal immunization; Oral adjuvant; RANKL

Indexed keywords

IMMUNOLOGICAL ADJUVANT; OSTEOCLAST DIFFERENTIATION FACTOR; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; RECOMBINANT PROTEIN; VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL MATURATION; CONTROLLED STUDY; EPITHELIUM CELL; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LACTOCOCCUS LACTIS; M CELL; MOUSE; MUCOSAL IMMUNITY; NONHUMAN; PROTEIN EXPRESSION; PROTEIN SECRETION; SIGNAL TRANSDUCTION; TRANSCYTOSIS; WILD TYPE; ANIMAL; CYTOLOGY; GENE EXPRESSION; GENETICS; IMMUNOLOGY; INTESTINE MUCOSA; METABOLISM; MICROBIOLOGY; ORAL DRUG ADMINISTRATION; PEYER PATCH;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, ORAL; ANIMALS; GENE EXPRESSION; INTESTINAL MUCOSA; LACTOCOCCUS LACTIS; MICE; PEYER'S PATCHES; RANK LIGAND; RECOMBINANT PROTEINS; VACCINES;

EID: 84947902145     PISSN: None     EISSN: 14712172     Source Type: Journal    
DOI: 10.1186/s12865-015-0132-x     Document Type: Article

References (32)

1. Holmgren J, Czerkinsky C. Mucosal immunity and vaccines. Nat Med. 2005;11:S45-53.
2. Park TE, Sing B, Maharjan S, Jiang T, Yoon SY, Kang SK, et al. Mucosal Delivery of Vaccine by M Cell Targeting Strategies. Curr Drug Ther. 2014;9:9-20.
3. Li H-S, Piao D-C, Jiang T, Bok J-D, Cho C-S, Lee Y-S, et al. Recombinant interleukin 6 with M cell-targeting moiety produced in Lactococcus lactis IL1403 as a potent mucosal adjuvant for peroral immunization. Vaccine. 2015;33:1959-67.
4. Ferko B, Kittel C, Romanova J, Sereinig S, Katinger H, Egorov A. Live attenuated influenza virus expressing human interleukin-2 reveals increased immunogenic potential in young and aged hosts. J Virol. 2006;80:11621-7.
5. Toka FN, Rouse BT. Mucosal application of plasmid-encoded IL-15 sustains a highly protective anti-Herpes simplex virus immunity. J Leukoc Biol. 2005;78:178-86.
6. Bracci L, Canini I, Puzelli S, Sestili P, Venditti M, Spada M, et al. Type I IFN is a powerful mucosal adjuvant for a selective intranasal vaccination against influenza virus in mice and affects antigen capture at mucosal level. Vaccine. 2005;23:2994-3004.
7. Foussat A, Balabanian K, Amara A, Bouchet-Delbos L, Durand-Gasselin I, Baleux F, et al. Production of stromal cell-derived factor 1 by mesothelial cells and effects of this chemokine on peritoneal B lymphocytes. Eur J Immunol. 2001;31:350-9.
8. Buda A, Sands C, Jepson MA. Use of fluorescence imaging to investigate the structure and function of intestinal M cells. Adv Drug Deliv Rev. 2005;57:123-34.
9. Yoo MK, Kang SK, Choi JH, Park IK, Na HS, Lee HC, et al. Targeted delivery of chitosan nanoparticles to Peyer's patch using M cell-homing peptide selected by phage display technique. Biomaterials. 2010;31:7738-47.
10. Rajapaksa TE, Stover-Hamer M, Fernandez X, Eckelhoefer HA, Lo DD. Claudin 4-targeted protein incorporated into PLGA nanoparticles can mediate M cell targeted delivery. J Control Release. 2010;142:196-205.
11. Kim SH, Yang IY, Jang SH, Kim J, Truong TT, Van Pham T, et al. C5a receptor-targeting ligand-mediated delivery of dengue virus antigen to M cells evokes antigen-specific systemic and mucosal immune responses in oral immunization. Microbes Infect. 2013;15:895-902.
12. Wang J, Gusti V, Saraswati A, Lo DD. Convergent and divergent development among M cell lineages in mouse mucosal epithelium. J Immunol. 2011;187:5277-85.
13. Valpotic H, Kovsca Janjatovic A, Lackovic G, Bozic F, Dobranic V, Svoboda D, et al. Increased number of intestinal villous M cells in levamisole -pretreated weaned pigs experimentally infected with F4ac(+) enterotoxigenic Escherichia coli strain. Eur J Histochem. 2010;54:e18.
14. Kunisawa J, Nochi T, Kiyono H. Immunological commonalities and distinctions between airway and digestive immunity. Trends Immunol. 2008;29:505-13.
15. Knoop KA, Kumar N, Butler BR, Sakthivel SK, Taylor RT, Nochi T, et al. RANKL is necessary and sufficient to initiate development of antigen-sampling M cells in the intestinal epithelium. J Immunol. 2009;183:5738-47.
16. Kanaya T, Hase K, Takahashi D, Fukuda S, Hoshino K, Sasaki I, et al. The Ets transcription factor Spi-B is essential for the differentiation of intestinal microfold cells. Nat Immunol. 2012;13:729-36.
17. Hikita A, Tanaka N, Yamane S, Ikeda Y, Furukawa H, Tohma S, et al. Involvement of a disintegrin and metalloproteinase 10 and 17 in shedding of tumor necrosis factor-alpha. Biochem Cell Biol. 2009;87:581-93.
18. Lloyd SA, Yuan YY, Kostenuik PJ, Ominsky MS, Lau AG, Morony S, et al. Soluble RANKL induces high bone turnover and decreases bone volume, density, and strength in mice. Calcif Tissue Int. 2008;82:361-72.
19. Theill LE, Boyle WJ, Penninger JM. RANK-L and RANK: T cells, bone loss, and mammalian evolution. Annu Rev Immunol. 2002;20:795-823.
20. Lo Iacono N, Pangrazio A, Abinun M, Bredius R, Zecca M, Blair HC, et al. RANKL cytokine: from pioneer of the osteoimmunology era to cure for a rare disease. Clin Dev Immunol. 2013;2013:412768.
21. Taylor RT, Patel SR, Lin E, Butler BR, Lake JG, Newberry RD, et al. Lymphotoxin-independent expression of TNF-related activation-induced cytokine by stromal cells in cryptopatches, isolated lymphoid follicles, and Peyer's patches. J Immunol. 2007;178:5659-67.
22. Garcia-Fruitos E. Lactic acid bacteria: a promising alternative for recombinant protein production. Microb Cell Fact. 2012;11:157.
23. Mercenier A, Muller-Alouf H, Grangette C. Lactic acid bacteria as live vaccines. Curr Issues Mol Biol. 2000;2:17-25.
24. Jiang T, Singh B, Maharjan S, Li HS, Kang SK, Bok JD, et al. Oral delivery of probiotic expressing M cell homing peptide conjugated BmpB vaccine encapsulated into alginate/chitosan/alginate microcapsules. Eur J Pharm Biopharm. 2014;88:768-77.
25. Lee BJ, La T, Mikosza AS, Hampson DJ. Identification of the gene encoding BmpB, a 30kDa outer envelope lipoprotein of Brachyspira (Serpulina) hyodysenteriae, and immunogenicity of recombinant BmpB in mice and pigs. Vet Microbiol. 2000;76:245-57.
26. Kim EB, da Piao C, Son JS, Choi YJ. Cloning and characterization of a novel tuf promoter from Lactococcus lactis subsp. lactis IL1403. Curr Microbiol. 2009;59:425-31.
27. Cuetara BL, Crotti TN, O'Donoghue AJ, McHugh KP. Cloning and characterization of osteoclast precursors from the RAW264.7 cell line. In Vitro Cell Dev Biol Anim. 2006;42:182-8.
28. Bossen C, Ingold K, Tardivel A, Bodmer JL, Gaide O, Hertig S, et al. Interactions of tumor necrosis factor (TNF) and TNF receptor family members in the mouse and human. J Biol Chem. 2006;281:13964-71.
29. Kobayashi A, Donaldson DS, Erridge C, Kanaya T, Williams IR, Ohno H, et al. The functional maturation of M cells is dramatically reduced in the Peyer's patches of aged mice. Mucosal Immunol. 2013;6:1027-37.
30. Zhang X, Hu S, Du X, Li T, Han L, Kong J. Heterologous expression of carcinoembryonic antigen in Lactococcus lactis via LcsB-mediated surface displaying system for oral vaccine development. J Microbiol Immunol Infect. 2014. doi: 10.1016/j.jmii.2014.11.009.
31. Takayanagi H. Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems. Nat Rev Immunol. 2007;7:292-304.
32. Takayanagi H, Kim S, Koga T, Nishina H, Isshiki M, Yoshida H, et al. Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev Cell. 2002;3:889-901.